share_log

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

SEC ·  Nov 21 05:33

Summary by Futu AI

Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.
Freda C. Lewis-Hall, reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US). On November 18, 2024, Lewis-Hall purchased 437,976 shares of common stock at a price of $0.0919 per share. Following this transaction, she directly holds a total of 437,976 shares. Additionally, she has an indirect beneficial ownership of 2,520,311 shares in the company, as detailed in the transaction report. The transaction has been marked as completed.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.